How Should Medical Aesthetic Clinics Adjust Treatment Protocols Based On Acne Grade? A Staged, Diagnosis-Led Approach With Professional Devices

Treatment protocols should become more conservative as acne severity increases. For Grade I and II acne, clinics can integrate selected non-ablative lasers, light-based systems, microneedling alternatives, microdermabrasion, and chemical exfoliation when the skin barrier is intact and inflammation is limited. Grade III acne generally requires medical control before significant device treatment, while Grade IV acne should be stabilized with physician-directed anti-inflammatory and antibacterial therapy before energy-based procedures are used for residual erythema, pigmentation, or scarring.

The guiding rule is to treat active inflammation first and tissue damage second. Energy-based devices may support management of mild acne, but aggressive laser or microneedling treatment over active, inflamed lesions can worsen irritation, infection risk, and post-inflammatory hyperpigmentation.

Match the Protocol to Acne Severity

Grade I: Predominantly comedonal acne

Grade I acne is generally characterized by open and closed comedones with minimal inflammation. The primary objectives are follicular decongestion, keratinization control, and prevention of progression.

Clinics may combine topical retinoids or azelaic acid with carefully selected superficial treatments, such as chemical peels, controlled exfoliation, microdermabrasion, or non-ablative resurfacing. Device intensity should remain modest because the condition does not justify aggressive dermal injury.

Microneedling is not usually the first-line device for uncomplicated comedonal acne. It is better reserved for persistent textural irregularity or established atrophic scarring after active acne is controlled.

Grade II: Mild inflammatory acne

Grade II acne includes comedones with a limited number of papules and pustules. Treatment can still incorporate professional devices, but the protocol must distinguish between non-inflamed areas and active lesions.

Non-ablative lasers or light-based systems may be used as adjuncts to medical and topical treatment. Their purpose may include moderating sebaceous activity, reducing inflammation, and improving early post-acne discoloration, depending on the device and its validated indication.

Superficial peels and controlled exfoliation can support cellular turnover, but repeated procedures should not compromise the skin barrier. Active pustules should not be aggressively traumatized with needles or abrasive devices.

Grade III: More extensive inflammatory acne

Grade III acne involves more numerous inflammatory lesions and may include deeper papules, pustules, or early nodular disease. At this stage, device treatment should become secondary to medical disease control.

A physician should assess the patient’s acne pattern, scarring risk, medication use, skin type, and likelihood of progression. Topical or systemic therapy may be needed before energy-based treatment is intensified.

Non-ablative light or laser treatment can sometimes be introduced as an adjunct once inflammation is improving. The clinic should avoid treating broadly across highly inflamed skin simply because the patient is seeking a procedure-based solution.

Grade IV: Severe inflammatory or nodulocystic acne

Grade IV acne requires medical stabilization before aggressive aesthetic intervention. Direct laser resurfacing, deep microneedling, or aggressive mechanical treatment over active nodules and cysts is initially contraindicated.

The first objective is to reduce inflammation and control bacterial involvement through physician-directed therapy. This stage may require dermatology referral or coordinated management rather than an aesthetic-only protocol.

After active disease is controlled, laser or light-based systems may address residual erythema, hyperpigmentation, and scar-related tissue changes. Microneedling or fractional resurfacing should be directed at stable scars, not untreated active lesions.

Use Devices for the Right Clinical Objective

Control active acne without creating additional inflammation

Energy-based devices should be selected according to the intended target: sebaceous activity, inflammatory lesions, vascular redness, pigment, or textural scarring. A device that is useful for remodeling scars is not automatically appropriate for active acne.

Some professional laser and light systems deliver energy into the dermis or target chromophores associated with sebaceous activity and inflammation. These effects may complement medical treatment, but they should not be represented as a substitute for diagnosing and treating moderate-to-severe acne.

Topical agents remain useful for bacterial control and abnormal follicular keratinization. They do not, by themselves, reliably reduce sebaceous gland size or sebum volume, which is where some energy-based approaches may provide an additional mechanism.

Treat scarring only after acne is stable

Microneedling creates controlled micro-injuries that activate wound healing and collagen remodeling. This makes it principally a scar-treatment procedure, rather than a general treatment for active inflammatory acne.

For mild to moderate atrophic scarring, commonly described as Grades 2 and 3 in scar-severity systems, a standard single-pass or multi-pass technique around 1.5 mm may produce meaningful remodeling. The exact depth must be adjusted for anatomic site, skin thickness, device design, and patient risk.

Severe, deep scars may require more intensive approaches, potentially including staged passes or combination treatment. A protocol using 1.5 mm followed by 3.0 mm, or higher micro-puncture density, should be reserved for appropriately trained clinicians and suitable scars after careful assessment.

Match scar morphology to the device

Fractional laser resurfacing is particularly suited to broad or relatively flat atrophic scars because it creates controlled columns of thermal injury that stimulate dermal neocollagenesis. It may be less effective as a standalone treatment for every scar type.

Ice-pick scars are narrow and deep, while boxcar scars have sharply defined edges and rolling scars are associated with dermal tethering. Deep boxcar or tethered rolling scars may require combination treatment, such as fractional resurfacing with subcision, rather than repeated laser passes alone.

Hypertrophic scars require a different management strategy from atrophic depressions. They should not be treated using an automatic “more energy equals better remodeling” approach.

Build a Safer Energy-Based Protocol

Start with assessment and staging

Before treatment, document acne grade, lesion type, scarring pattern, skin phototype, medication exposure, history of hyperpigmentation, and previous treatment response. Confirm whether the planned procedure is intended for active acne, pigment, vascular redness, pores, or scars.

Acne grades and scar grades are not interchangeable. A patient may have controlled Grade IV acne with Grade 3 or Grade 4 scarring, requiring separate treatment phases.

Use conservative energy delivery

For patients at risk of pain or post-inflammatory hyperpigmentation, particularly those with Fitzpatrick skin types III and darker, conservative energy delivery is important. Lower fluence across multiple passes may be preferable to a high-energy single pass when the device and indication support that approach.

Values such as 8–9 J/cm² should not be treated as universal settings. Fluence, pulse width, spot size, density, cooling, and pass count must be selected according to the specific platform, indication, skin type, treatment area, and manufacturer guidance.

Longer pulse widths, larger spot sizes, and active contact cooling may improve tolerance in appropriate laser applications. They do not eliminate the need for test spots, informed consent, eye protection, infection control, and post-treatment monitoring.

Separate active-acne and scar-treatment visits when necessary

Treating active inflammation and scarring in the same session can increase cumulative irritation. A staged pathway is often more appropriate: stabilize acne, reassess the skin, then select a scar-specific intervention.

The interval between procedures should allow erythema, edema, crusting, and barrier disruption to resolve. Patients should also receive clear instructions regarding sun protection, topical medication pauses, cleansing, and signs of infection or abnormal healing.

Understanding the Trade-offs

More aggressive treatment is not automatically more effective

Deeper needles, higher fluence, and greater treatment density may increase the potential for remodeling, but they also increase pain, downtime, inflammation, and pigmentary complications. The correct endpoint is controlled treatment injury, not maximal visible trauma.

Deep microneedling also depends on technique. Manual skin stretching affects penetration, particularly when using longer needles, but stretching should never be used to justify unsafe depth or pressure.

Microneedling can worsen active disease

Needling over pustules, nodules, cysts, or clinically infected skin can distribute inflammation and increase the risk of complications. It may also produce unnecessary trauma when the patient’s primary problem is untreated acne rather than scarring.

Active acne should therefore be evaluated before every session, even when the patient is returning for a previously planned scar protocol.

Combination therapy increases complexity

Combining peels, retinoids, lasers, radiofrequency microneedling, and other procedures can produce additive irritation. It can also make it difficult to determine which treatment caused a flare, burn, prolonged redness, or pigment change.

Protocols should therefore introduce changes sequentially where practical and define explicit stopping criteria. Device selection should be based on clinical demand and practitioner competence rather than attempting to make one platform treat every condition.

How to Apply This to Your Clinic

Use a staged protocol that treats disease activity first and scar morphology afterward.

If your primary focus is mild Grade I acne: Prioritize topical keratinization control and carefully selected superficial peels, exfoliation, or non-ablative treatments while avoiding unnecessary deep tissue injury.
If your primary focus is Grade II acne: Combine medical therapy with conservative non-ablative laser or light-based treatment when appropriate, and keep microneedling away from active pustules and inflamed lesions.
If your primary focus is Grade III acne: Make physician-led disease control the foundation, introducing device treatment only as an adjunct once inflammation is clearly improving.
If your primary focus is Grade IV acne: Stabilize the patient medically before using lasers, deep microneedling, or aggressive mechanical procedures; treat residual redness, pigment, and scarring later.
If your primary focus is atrophic acne scarring: Select the device and depth according to scar severity and morphology, using conservative settings first and considering combination procedures for deep boxcar or tethered rolling scars.
If your primary focus is darker skin phototypes: Favor conservative, distributed energy delivery with appropriate cooling and monitoring, because post-inflammatory hyperpigmentation risk must be actively managed.

The most reliable protocol is staged, diagnosis-led, and conservative enough to improve the skin without creating a second inflammatory problem.

Summary Table:

Acne Grade	Characteristics	Device Protocol	Key Considerations
Grade I	Comedonal, minimal inflammation	Modest non-ablative lasers, superficial peels, exfoliation	Avoid aggressive injury; focus on follicular decongestion
Grade II	Limited papules/pustules	Conservative non-ablative lasers, light-based systems	Keep away from active lesions; support barrier
Grade III	Extensive inflammation	Secondary to medical control; adjunct non-ablative devices	Treat inflammation first; avoid high-intensity treatments
Grade IV	Severe nodulocystic	No aggressive lasers/microneedling until stabilized	Medical stabilization first; address residual issues later

Optimize your clinic's acne treatment protocols with state-of-the-art devices from BELIS. Whether you're addressing mild comedonal acne or severe scarring, our professional-grade laser and microneedling systems—including Diode, Alexandrite, CO2 Fractional, and Microneedle RF—are designed for safe, effective, and tailored treatment. Partner with us to elevate your practice and deliver superior patient outcomes. Contact us today to learn more about our OEM/ODM support and comprehensive aesthetic solutions.